TRuE AD1 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: Ruxolitinib cream;   Drug: Vehicle cream Sponsor:   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials